WALTHAM, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA) announced today the following correction to its press release dated January 31, 2008 and entitled "Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008." The press release incorrectly stated the time of the Company's presentation. The correct time of the presentation is Tuesday, February 5, 2008 at 8:40 a.m.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.
|SOURCE Inverness Medical Innovations, Inc.|
Copyright©2008 PR Newswire.
All rights reserved